Oncovita

About Oncovita

Oncovita is a preclinical stage biotech company focused on pioneering the development of oncolytic viruses to address unmet medical needs in cancer treatment. The company aims to deliver safe and efficient therapies against hematological cancers and solid tumors using its proprietary MeasovirTM platform, with a mission to unleash the patient's own power to fight cancer with effective vaccines.

Products & Services

MeasovirTM Platform:A proprietary platform using a DNA plasmid vector to express a modified measles Schwarz virus antigenome, designed to kill cancer cells and activate the immune system.

MVdeltaC:An immunotherapeutic vaccine candidate for oncology, specifically targeting cancers like pleural mesothelioma, with FDA Orphan Drug Designation.

Immuno-oncolytic Viruses:Engineered viruses that target cancer cells, promote immunogenic death, and enhance antitumor immune responses.

Measles Vaccine-Based Therapies:Therapies based on the attenuated measles virus, known for safety and efficacy, adapted for cancer treatment.

Specialties

Oncolytic Viruses Cancer Immunotherapy Prophylactic Vaccinology Hematological Cancers Solid Tumors Measles Virus-Based Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant and Private Financing Round T: - FT: Grant and Private Financing Round	A: 8500000 MR: - FA: €8 million FAN: 8500000	D: 2023-11-29 FD: 2023-11-29	2 investors

Grant and Private Financing Round Latest

2023-11-29

$8.5M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Stéphane Champiat

Medical Advisor

M

Marc Grégoire

Doctor

F

Frédéric Tangy

Co-Founder and Chief Scientific Officer

S

Stanley A. Plotkin

Emeritus Professor

J

Jean-François Saluzzo

Pharm D, Dr.Sc.

J

Jean-François Le Bigot

Executive Chairman of Oncovita

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Oncovita Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised